Coya Therapeutics, Inc.(COYA)

$5.26—

Chart

Coya Therapeutics, Inc.(COYA)

NASDAQ

$5.26—

Chart Studio

COYA(COYA)

COYA

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.36

Aug 11, 2026 · Reports before open

Revenue Estimate

$130,000

Analyst Sentiment

Wall St. Consensus

Buy

5 analysts·Limited coverage

Score

5 Buy (100%)0 Hold (0%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

5100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$12.00

+128.1%

Consensus

$12.00

+128.1%

Bull

$12.00

+128.1%

12-Month Target Range5 analysts

$12.00$12.00$12.00

Current $5.26Consensus

Current Price

$5.26

Upside to Consensus

$6.74

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+109.47%

EPS—

FY2028

Rev+294.01%

EPS—

FY2029

Rev-94.88%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$2M	$5M	$20M	$1M	$1M
Low	$1M	$5M	$3M	$171,708	$171,708
High	$5M	$5M	$77M	$4M	$4M
EBITDA Avg	$-473,742	$-992,366	$-4M	$-199,999	$-199,999
Low	$-997,353	$-992,366	$-15M	$-784,922	$-784,922
High	$-207,781	$-992,366	$-671,379	$-34,341	$-34,341
EBIT Avg	$-473,742	$-992,366	$-4M	$-199,999	$-199,999
Low	$-997,353	$-992,366	$-15M	$-784,922	$-784,922
High	$-207,781	$-992,366	$-671,379	$-34,341	$-34,341
Net Income Avg	$-23M	$-23M	$-19M	$-38M	$-41M
Low	$-23M	$-24M	$-35M	$-183M	$-198M
High	$-22M	$-22M	$-2M	$3M	$3M
EPS Avg	$-1.36	$-1.39	$-1.10	$-2.28	$-2.46
Low	$-1.38	$-1.44	$-2.08	$-10.95	$-11.81
High	$-1.34	$-1.34	$-0.12	$0.18	$0.19
Analysts (Rev / EPS)	5 / 4	6 / 3	2 / 2	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$100,000	$2M	$75,000	$100,000	$100,000	$100,000	$331,005	$342,628
Low	$100,000	$2M	$75,000	$100,000	$100,000	$100,000	$331,005	$342,628
High	$100,000	$2M	$75,000	$100,000	$100,000	$100,000	$331,005	$342,628
EBITDA Avg	$-19,999	$-379,999	$-14,999	$-19,999	$-19,999	$-19,999	$-66,200	$-68,525
Low	$-19,999	$-379,999	$-14,999	$-19,999	$-19,999	$-19,999	$-66,200	$-68,525
High	$-19,999	$-379,999	$-14,999	$-19,999	$-19,999	$-19,999	$-66,200	$-68,525
EBIT Avg	$-19,999	$-379,999	$-14,999	$-19,999	$-19,999	$-19,999	$-66,200	$-68,525
Low	$-19,999	$-379,999	$-14,999	$-19,999	$-19,999	$-19,999	$-66,200	$-68,525
High	$-19,999	$-379,999	$-14,999	$-19,999	$-19,999	$-19,999	$-66,200	$-68,525
Net Income Avg	$-6M	$-6M	$-7M	$-7M	$-5M	$-7M	$-5M	$-5M
Low	$-6M	$-6M	$-7M	$-7M	$-5M	$-7M	$-5M	$-5M
High	$-6M	$-6M	$-7M	$-7M	$-5M	$-7M	$-5M	$-5M
EPS Avg	$-0.37	$-0.33	$-0.40	$-0.42	$-0.30	$-0.40	$-0.31	$-0.29
Low	$-0.38	$-0.33	$-0.40	$-0.42	$-0.30	$-0.40	$-0.31	$-0.29
High	$-0.36	$-0.33	$-0.40	$-0.42	$-0.30	$-0.40	$-0.31	$-0.29
Analysts (Rev / EPS)	7 / 3	4 / 1	4 / 1	3 / 1	3 / 1	3 / 1	2 / 1	5 / 1

Earnings Surprises

Recent Analyst Actions

Jun 5, 2026Roth Capital

Coya Therapeutics initiated with a Buy at Roth Capital

Target:$12.00

+146.4%from $4.87

Nov 5, 2025Lake Street

Coya Therapeutics price target raised to $17 from $16 at Lake Street

Target:$17.00

+195.1%from $5.76

Sep 16, 2024H.C. Wainwright

This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday

Target:$18.00

+194.1%from $6.12

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance